.Nature Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint requires incorporation of people along with MASLD and also dimension of liver results in cardio-- renal-- metabolic trials, when information suggest mechanistically conceivable benefits as well as professional safety and security-- and summarizes factors for trial concept and regulatory approval.